VIV RX Review

What VIV RX charges

• NAD+: $124 — from — the shop grid and the product page both print this as a floor per month
• Sermorelin: $124 — from — the shop grid and the product page both print this as a floor per month
• Glutathione: $99 — from — the shop grid and the product page both print this as a floor per month

One shell, several products

The shop is a hash-routed application, so every product address serves the same small document with no figure in it.

A checker reading served HTML would have found one page and no prices, and would have been wrong about both.

Rendered at each product's own hash route, the three tracked compounds each carry their own figure, route and frequency.

The nonsense-path control on the same host renders a single sentence saying the page does not exist, against a shop page many times its length.

Every figure is a floor

Each product prints its figure under the word from, which makes it the bottom of a range rather than the price of anything.

The shop grid and the product page agree with each other, which is worth recording because another seller read in the same run prints two different starting figures for one product.

What a buyer actually pays depends on a dose that is set after an evaluation, and the seller does not publish that ladder.

The figures are recorded as floors rather than as rates, so nothing downstream can present them as what a month costs.

A licence held by somebody else

The seller says its medication is compounded at a state-licensed pharmacy registered with the federal regulator.

That is a licence held by an unnamed third party, and it is not the same fact as naming the facility that fills an order.

On the same line the seller says plainly that registration is not approval, which is more candour than the category usually offers.

There is no corporate form published anywhere on the pages read; the only entity name for this seller comes from the federal warning-letter record.

What is included, and what is not

Each product lists what the plan covers as a set of named items rather than as a general promise.

That list holds the medication, the injection supplies and the provider visit with dose adjustments.

Lab work appears nowhere in it, which is why nothing on this row treats testing as part of the price.

Availability is said to vary by state and no list is published, so eligibility is settled inside the intake.

FDA disclosure

VIV RX received an FDA warning letter issued February 2026. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.

How we verified this

• Read every page cited on this row as rendered text in a real browser, not as served HTML, because several sellers in this pass ship the figure in by script and serve a bare currency sign.
• Fired a nonsense-path control at this host in the same run and judged it on the rendered document rather than on its status code or its byte count.
• Joined every text node before scanning for a currency sign, so a figure split across nested elements could not read as an absence.
• Clicked every collapsed accordion on the pages read, because pharmacy names, state answers and lab conditions hid inside them on most sellers checked this pass.
• Read each figure inside its own card or panel rather than by nearness to a compound name, on pages that price weight-loss lines beside peptide lines.
• Recorded the seller's own published figure and never divided a multi-month total into a monthly one.
• Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
• Read the company column of every returned record rather than accepting a full-text match, and attached no letter unless the letter itself named this seller's own domain.
• Rendered each product at its own hash route rather than assuming one shop page held them all.
• Read the inclusion list item by item before deciding whether lab work was part of it.
• Kept the entity name from the federal record out of the claims about what this seller publishes about itself.